Thanks to visit codestin.com
Credit goes to guardianresearch.substack.com

Guardian Research

Guardian Research

Home
Chat
Performance
Archive
About
GUARDIAN RESEARCH 2026 OUTLOOK
Guardian's Top Picks for 2026 are Here.
 • Guardian Research
Guardian Research Watchlist Update (Dec 31)
Stocks in the pipeline that have cleared our initial diligence
 • Guardian Research
STRATA Critical Medical (NASDAQ: SRTA): The Orphan in Organ Logistics
A Neglected Organ-Logistics Asset With 100% Upside Potential
 • Guardian Research
Founding Reader Pricing (Ends Dec 29)
One-time Holiday discount to Guardian Research before most content goes paywalled in 2026.
 • Guardian Research
Heads You Win, Tails You...Also Win: $WLAC
Capped downside, returning SPAC sentiment, and a misunderstood asset underneath
 • Guardian Research
Fair Winds to Fifty and Above: $NCLH
No longer between the devil and the deep blue sea
 • Guardian Research
Guardian Research Watchlist Update (Dec 11th)
Stocks in the pipeline that have cleared our initial diligence
 • Guardian Research
SpaceX Gets the Headlines; $RDW Is Cooking Up a 10x Move in the Basement (NYSE: RDW)
A diversified bet on the final frontier and a potential space-sentiment proxy for public markets.
 • Guardian Research
Guardian Research
Guardian Research
Independent Research on Emerging Themes and Asymmetric Opportunities so you can Invest with Conviction
Recommendations
View all 12
The Pursuit of Compounding
The Pursuit of Compounding
The Pursuit of Compounding
Algorithm
Algorithm
Algorithm
User's avatar
Case Resources
Case Resources
User's avatar
Arkenstone Research
Arkenstone Research
Unfair Advantage
Unfair Advantage
AK

Guardian Research

AboutArchiveRecommendationsSitemap
© 2026 Matthew Stone · Privacy ∙ Terms ∙ Collection notice
Codestin Search App Start your SubstackGet the app
Substack is the home for great culture